Symposium : Precision oncology in Quebec - From laboratory to patient... precisely!

Repare Therapeutics is organizing a symposium on precision oncology on June 19, from 10 a.m. to 1 p.m. at the adMare Innovation Center in Montreal. Join us at to see how their drug discovery efforts translate into biomarker-selected clinical trials, then learn from patients of their experience fighting a very personal battle against cancer. 

This is a rare opportunity to learn about the entire spectrum of oncology from lab to patient with a particular emphasis on the importance of using NGS to get the right drug into the right patient. 

This event is now sold out. Please contact Natatlie Laurence at nlaurence@reparerx.com for more information.

Panelists: 

Panel A: Discovery/Translation

• Jordan Young, Ph.D., Senior Director - Oncology Discovery, Repare Therapeutics
• Anne Roulston, Ph.D., Senior Director - Pharmacology, Repare Therapeutics
• Dr. Mark Basik, MD, Cancer Genomics and Translational Research Laboratory, Lady Davis Institute for Medical Research

Panel B: Clinical Development

• Dr. Lucy Gilbert, MD, Professor and Chair, Gerald Bronfman Department of Oncology, Robert Kinch Chair in Women’s Health, Department of Obstetrics and Gynecology, Faculty of Medicine and Health Sciences, McGill University
• Dr. Diane Provencher, MD, Chef de la Division de gynécologie oncologique, Université de Montréal
• Olivier Jérôme, Director Engagement, Partnerships and Strategic Initiatives, CATALIS Québec

Panel C: Patient Experience

• Led by Valérie Dinh, Québec Regional Director, Ovarian Cancer Canada.

The event is opened to all stakeholders from life science industry, academia, hospitals and government interested to see what the future of precision oncology looks like in Quebec.